U.S. Markets close in 5 hrs 40 mins

Enzon Pharmaceuticals, Inc. (ENZN)

OTC Markets - OTC Markets Delayed Price. Currency in USD
Add to watchlist
0.395+0.005 (+1.282%)
As of 9:46AM EDT. Market open.
People also watch
QLTIALKSPDLIMYGNARQL
Full screen
Previous Close0.390
Open0.390
Bid0.000 x 0
Ask0.000 x 0
Day's Range0.385 - 0.395
52 Week Range0.220 - 0.500
Volume18,199
Avg. Volume70,715
Market Cap17.46M
Beta0.71
PE Ratio (TTM)-7.90
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield0.00 (0.00%)
Ex-Dividend Date2015-12-30
1y Target EstN/A
Trade prices are not sourced from all markets
  • Enzon Pharmaceuticals, Inc. :ENZN-US: Earnings Analysis: Q1, 2017 By the Numbers : May 18, 2017
    Capital Cube3 months ago

    Enzon Pharmaceuticals, Inc. :ENZN-US: Earnings Analysis: Q1, 2017 By the Numbers : May 18, 2017

    Categories: Yahoo FinanceGet free summary analysis Enzon Pharmaceuticals, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Enzon Pharmaceuticals, Inc. – Nektar Therapeutics, Amgen Inc., Enanta Pharmaceuticals, Inc., Pfizer Inc., Merck & Co., Inc., Valeant Pharmaceuticals International Inc, XOMA Corporation, SciClone Pharmaceuticals, Inc., Gilead Sciences, ... Read more (Read more...)

  • Enzon Pharmaceuticals, Inc. :ENZN-US: Earnings Analysis: Q4, 2016 By the Numbers : March 28, 2017
    Capital Cube5 months ago

    Enzon Pharmaceuticals, Inc. :ENZN-US: Earnings Analysis: Q4, 2016 By the Numbers : March 28, 2017

    Categories: Yahoo Finance Get free summary analysis Enzon Pharmaceuticals, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Enzon Pharmaceuticals, Inc. – Nektar Therapeutics, Amgen Inc., Enanta Pharmaceuticals, Inc., Pfizer Inc., Merck & Co., Inc., Valeant Pharmaceuticals International Inc, XOMA Corporation, SciClone Pharmaceuticals, Inc. and Gilead ... Read more (Read more...)

  • Carl Icahn Takes 15% Stake in Enzon Pharmaceuticals
    GuruFocus.com9 months ago

    Carl Icahn Takes 15% Stake in Enzon Pharmaceuticals

    Activist investor continues his interest in penny stock